36705-82-5

Basic information

• Product Name: 4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-
• Synonyms: 4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-;2-(4-Hydroxy-phenyl)-thiazole-4-carboxylic acid;2-(4-hydroxyphenyl)-4-thiazolecarboxylic acid
• CAS NO: 36705-82-5
• Molecular Formula: C₁₀H₇NO₃S
• Molecular Weight: 221.23248
• Mol File: 36705-82-5.mol

Chemical Properties

• Melting Point: 218-221 °C
• Boiling Point: 493.0±51.0 °C(Predicted)
• Appearance: /
• Density: 1.490±0.06 g/cm3(Predicted)
• PKA: 8.89±0.15(Predicted)
• CAS DataBase Reference: 4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-(36705-82-5)
• EPA Substance Registry System: 4-Thiazolecarboxylic acid, 2-(4-hydroxyphenyl)-(36705-82-5)

Safety Data

• Hazardous Substances Data: 36705-82-5(Hazardous Substances Data)

Upstream product

• 25984-63-8 4-hydroxythiobenzamide 
• 1113-59-3 bromopyruvic acid 
• 767-00-0 4-cyanophenol 
• 36727-07-8 2-(4-hydroxy-phenyl)-thiazole-4-carboxylic acid methyl ester 

Downstream Products

• 133477-33-5 2-(4-Hydroxyphenyl)-1,3-thiazole-4-carboxamide 
• 1007578-74-6 2-{4-[(2-chloroethyl)oxy]phenyl}-1,3-thiazole-4-carboxamide 

Relevant articles and documents

As opioid receptor antagonists or inverse agonists of the novel compounds

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS

Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.

METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS

A method of treatment using pharmaceutical compositions containing novel antagonists or inverse agonists at opioid receptors for the treatment of binge eating disorder, anorexia nervosa, bulimia nervosa, excess drug or alcohol use, or eating disorder not otherwise specified.